LEP and Alzheimer disease: Moreover, we show that while 3xTg-AD mice have early and mid-life metabolic changes, including increased peripheral fat accumulation and circulating leptin as well as impaired resting glucose and glucose tolerance, 1-month ICV infusion of SCDi in mid-life does not normalize these parameters.